Elizabeth Parrish, MBA

Elizabeth (Liz) Parrish, MBA, is the Founder and CEO of BioViva Sciences USA Inc., a biotechnology company dedicated to extending healthy human lifespans through gene therapy. BioViva specializes in combinatorial gene therapies, leveraging its proprietary CMV gene therapy delivery platform to advance cutting-edge treatments.

A distinguished entrepreneur, author, and innovator, Liz is a leading advocate for the Best Choice Medicine (BCM) plan, a regulatory framework designed to streamline and accelerate the approval of genetic therapies. She is actively engaged in international educational outreach and has spoken at prestigious conferences worldwide, including WIRED, TEDx, and other high-profile forums.

Liz has been published in multiple books, including contributing an academic chapter to Springer, further solidifying her role as a thought leader in the field. She views cellular aging as a disease and believes that advancements in space research will not only contribute to healthier and longer lifespans but also enhance the safety of space travel and drive breakthroughs in curative medicine, particularly for patients under the age of 20.

• Clinical Genetics
• Epigenetics